Latisse is a prescription ophthalmic solution approved by the FDA used in the treatment of hypotrichosis, which is generally a condition in which very scanty eyelashes are present in patients. Latisse’s active ingredient steadily raises the number of eyelashes while also making them fuller, longer, and thicker. The entire procedure takes about 16 weeks, but it is possible to see results after 8 weeks. Patients with hypotrichosis are treated with Latisse by plastic surgeons, ophthalmologists, dermatologists, and physicians who specialise in primary eye treatment.Do you want learn more look here
Latisse Discovery for Treatment
In 2001, Allergan was used to treat patients with elevated intraocular pressure (IOP) with the active ingredient bimatoprost and found that this prostaglandin analogue receptor made the eyelashes grow longer, darker and thicker. In 2008, the FDA approved Latisse, which contains this active ingredient, and used it to treat patients who wanted to improve their eyelashes.
According to clinical research on Latisse, nearly 78 percent of women and men saw a substantial improvement in prominent eyelashes in terms of length, colour, and fullness. To use Latisse, all traces of make-up must be removed, and the eyelids must be thoroughly washed. During application, contact lenses should be removed. A drop of ophthalmologic fluid is then added to the base of the upper eyelids with an applicator brush. This is generally not approved for use on the lower lash line because it can cause hair to grow around the treated area, giving it an unattractive appearance.
Clinical Research Results
Almost 78 percent of participants indicated that their lashes grew longer, thicker, and darker during the 16-week treatment period. Almost 106 percent of people said their eyelashes had grown full and thick. The growth cycle known as anagen increases the hair cycle level, which has this effect on the eyelashes in turn. During this 16 week span, the percentage of elevated hair is important.